Get started
Author

Sagiru Hamza Abdullahi

Observed institution: Ahmadu Bello University
ORCID: 0000-0002-2976-9636
Observed ORCID: 0000-0002-2976-9636
OpenAlex ID: A5046028790
In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line
2022 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Bulletin of the National Research Centre/Bulletin of the National Research Center · 58
PDF
Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies
2023 · Sagiru Hamza Abdullahi, Abu Tayab Moin, et al. · Intelligent Pharmacy · 49
Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents
2021 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Bulletin of the National Research Centre/Bulletin of the National Research Center · 43
PDF
Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents
2022 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Bulletin of the National Research Centre/Bulletin of the National Research Center · 40
PDF
Molecular Docking , ADMET and Pharmacokinetic properties predictions of some di-aryl Pyridinamine derivatives as Estrogen Receptor (Er+) Kinase Inhibitors
2022 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Egyptian Journal of Basic and Applied Sciences · 29
Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
2023 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Journal of the Egyptian National Cancer Institute · 20
PDF
Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents
2023 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Journal of Taibah University Medical Sciences · 19
Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies
2023 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Biocatalysis and Agricultural Biotechnology · 16
2D and 3D-QSAR Modeling of 1H‑Pyrazole Derivatives as EGFR Inhibitors: Molecular Docking, and Pharmacokinetic Profiling
2023 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Chemistry Africa · 16
Structure Based Design of Some Novel 3-Methylquinoxaline Derivatives Through Molecular Docking and Pharmacokinetics Studies as Novel VEGFR-2 Inhibitors
2022 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Chemistry Africa · 15
In-silico design of some pyrazolopyridine analogs as breast cancer inhibitors: QSAR modeling, molecular docking, MD simulation, and pharmacological features profiling
2023 · Sagiru Hamza Abdullahi, Adamu Uzairu, et al. · Journal of the Indian Chemical Society · 9
Unveiling novel VEGFR-2 inhibitors: QSAR modeling, molecular docking, MD and MM-GBSA calculations, pharmacokinetics profiling and DFT studies
2025 · Sagiru Hamza Abdullahi, Rajesh B. Patil, et al. · Scientific African · 4
Design of some phthalazine molecules as novel VEGFR-2 target inhibitors through 3D-QSAR modeling, molecular docking and dynamic simulation and pharmacokinetics profiling
2024 · Abdullahi Bello Umar, Sagiru Hamza Abdullahi, et al. · Journal of Umm Al-Qura University for Applied Sciences · 3
PDF
DFT and molecular dynamics exploration of 2-[2-(hydroxybenzylidene)amino]benzoic acid, and (2-hydroxybenzylidene)-(2-hydroxyphenyl)amine Schiff bases as green corrosion inhibitors for mild steel
2026 · Magaji Ladan, Zakariyya Danyaro, et al. · Discover Chemistry. · 2
PDF
Design of novel BRC1A target inhibitors: Docking simulation, QSAR modeling, MD simulation and Pharmacokinetics profiling
2024 · Sagiru Hamza Abdullahi, Nainee Goyal, et al. · Scientific African · 2
In Silico evaluation of naphthalene-based tubulin inhibitors as potential anticancer agents targeting breast cancer cells
2026 · Sagiru Hamza Abdullahi, Renato Araujo da Costa, et al. · Scientific African
Works count: 17
Citation count: 325
H-index: 10
I10-index: 10
Year
Topic
Type